Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Myeloid sarcoma
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Treatment == As described above, chloromas should always be considered manifestations of systemic disease, rather than isolated local phenomena, and treated as such. In the patient with newly diagnosed leukemia and an associated chloroma, systemic chemotherapy against the leukemia is typically used as the first-line treatment, unless an indication for local treatment of the chloroma (e.g. compromise of the [[spinal cord]]) emerges. Chloromas are typically quite sensitive to standard antileukemic [[chemotherapy]]. Allogeneic hematopoietic stem cell transplantation should be considered in fit patients with suitable available donor, as long term remissions have been reported.<ref>{{cite journal |vauthors=Kaur V, Swami A, Alapat D, etal |title=Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years |journal=Hematology |volume=23 |issue=1 |pages=17β24 |pmid=28574302 |doi=10.1080/10245332.2017.1333275|year=2018 |doi-access=free }}</ref> If the chloroma is persistent after completion of induction chemotherapy, local treatment, such as [[surgery]] or [[radiation therapy]], may be considered, although neither has an effect on survival.<ref>{{cite journal |vauthors=Imrie KR, Kovacs MJ, Selby D, etal |title=Isolated chloroma: the effect of early antileukemic therapy |journal=Ann. Intern. Med. |volume=123 |issue=5 |pages=351β3 |date=September 1995 |pmid=7625623 |doi=10.7326/0003-4819-123-5-199509010-00005|s2cid=20631629 }}</ref> Patients presenting with a primary chloroma typically receive systemic chemotherapy, as development of acute leukemia is nearly universal in the short term after detection of the chloroma. Patients treated for acute leukemia who relapse with an isolated chloroma are typically treated with systemic therapy for relapsed leukemia. However, as with any relapsed leukemia, outcomes are unfortunately poor. Patients with "preleukemic" conditions, such as [[myelodysplastic syndrome]]s or myeloproliferative syndromes, who develop a chloroma are often treated as if they have transformed to acute leukemia.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)